Acute Renal Failure (ARF) (Acute Kidney Injury) Global Clinical Trials Review, H1, 2017

GlobalData
219 Pages - GLDATA60414
$2,500.00

Summary

GlobalData's clinical trial report, “Acute Renal Failure (ARF) (Acute Kidney Injury) Global Clinical Trials Review, H1, 2017" provides an overview of Acute Renal Failure (ARF) (Acute Kidney Injury) clinical trials scenario. This report provides top line data relating to the clinical trials on Acute Renal Failure (ARF) (Acute Kidney Injury). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Companies Mentioned

AbbVie Inc
Action Pharma A/S
Complexa Inc
Baxter International Inc
Am-Pharma BV
SBI Biotech Co Ltd
Fresenius SE & Co KGaA
Exponential Biotherapies Inc
DURECT Corp
Adrenomed AG

'

Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 3
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Acute Renal Failure (ARF) (Acute Kidney Injury) to Genito Urinary System And Sex Hormones Clinical Trials 15
Clinical Trials by Phase in G7 Countries 17
Clinical Trials in G7 Countries by Trial Status 18
Clinical Trials by E7 Countries: Proportion of Acute Renal Failure (ARF) (Acute Kidney Injury) to Genito Urinary System And Sex Hormones Clinical Trials 20
Clinical Trials by Phase in E7 Countries 21
Clinical Trials in E7 Countries by Trial Status 23
Clinical Trials by Phase 26
In Progress Trials by Phase 27
Clinical Trials by Trial Status 28
Clinical Trials by End Point Status 30
Subjects Recruited Over a Period of Time 31
Clinical Trials by Sponsor Type 32
Prominent Sponsors 33
Top Companies Participating in Acute Renal Failure (ARF) (Acute Kidney Injury) Therapeutics Clinical Trials 35
Prominent Drugs 37
Latest Clinical Trials News on Acute Renal Failure (ARF) (Acute Kidney Injury) 38
Jan 31, 2017: Angion Biomedica Phase 2 “GUARD” Clinical Trial of BB3 in Acute Kidney Injury (AKI) Underway; Complements Ongoing Phase 3 Study in Renal Transplant Recipients with Delayed Graft Function 38
Jan 30, 2017: DURECT Announces Update on DUR-928 Development Program 38
Dec 09, 2016: ROSGard shows renal protective effect during radiation therapy 39
Clinical Trial Profile Snapshots 40
Appendix 216
Abbreviations 216
Definitions 216
Research Methodology 217
Secondary Research 217
About GlobalData 218
Contact Us 218
Disclaimer 218
Source 219

List of Tables
Acute Renal Failure (ARF) (Acute Kidney Injury) Therapeutics, Global, Clinical Trials by Region, 2017* 6
Acute Renal Failure (ARF) (Acute Kidney Injury) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 8
Acute Renal Failure (ARF) (Acute Kidney Injury) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 9
Acute Renal Failure (ARF) (Acute Kidney Injury) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2017* 10
Acute Renal Failure (ARF) (Acute Kidney Injury) Therapeutics Clinical Trials, Europe, Top Five Countries, 2017* 11
Acute Renal Failure (ARF) (Acute Kidney Injury) Therapeutics Clinical Trials, North America, Top Countries, 2017* 12
Acute Renal Failure (ARF) (Acute Kidney Injury) Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2017* 13
Acute Renal Failure (ARF) (Acute Kidney Injury) Therapeutics Clinical Trials, Central and South America, Top Countries, 2017* 14
Proportion of Acute Renal Failure (ARF) (Acute Kidney Injury) to Genito Urinary System And Sex Hormones Clinical Trials, G7 Countries (%), 2017* 16
Acute Renal Failure (ARF) (Acute Kidney Injury) Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 17
Acute Renal Failure (ARF) (Acute Kidney Injury) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 19
Proportion of Acute Renal Failure (ARF) (Acute Kidney Injury) to Genito Urinary System And Sex Hormones Clinical Trials, E7 Countries (%), 2017* 20
Acute Renal Failure (ARF) (Acute Kidney Injury) Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 21
Acute Renal Failure (ARF) (Acute Kidney Injury) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 24
Acute Renal Failure (ARF) (Acute Kidney Injury) Therapeutics, Global, Clinical Trials by Phase, 2017* 26
Acute Renal Failure (ARF) (Acute Kidney Injury) Therapeutics, Global, Clinical Trials In Progress by Phase 2017* 27
Acute Renal Failure (ARF) (Acute Kidney Injury) Therapeutics, Global, Clinical Trials by Trial Status, 2017* 29
Acute Renal Failure (ARF) (Acute Kidney Injury) Therapeutics Clinical Trials, Global, by End Point Status, 2017* 30
Acute Renal Failure (ARF) (Acute Kidney Injury) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 31
Acute Renal Failure (ARF) (Acute Kidney Injury) Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2017* 32
Acute Renal Failure (ARF) (Acute Kidney Injury) Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 34
Acute Renal Failure (ARF) (Acute Kidney Injury) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 36
Acute Renal Failure (ARF) (Acute Kidney Injury) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 37

List of Figures
Acute Renal Failure (ARF) (Acute Kidney Injury) Therapeutics, Global, Clinical Trials by Region (%), 2017* 6
Acute Renal Failure (ARF) (Acute Kidney Injury) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 7
Acute Renal Failure (ARF) (Acute Kidney Injury) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 9
Acute Renal Failure (ARF) (Acute Kidney Injury) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2017* 10
Acute Renal Failure (ARF) (Acute Kidney Injury) Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2017* 11
Acute Renal Failure (ARF) (Acute Kidney Injury) Therapeutics Clinical Trials, North America, Top Countries (%), 2017* 12
Acute Renal Failure (ARF) (Acute Kidney Injury) Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2017* 13
Acute Renal Failure (ARF) (Acute Kidney Injury) Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2017* 14
Proportion of Acute Renal Failure (ARF) (Acute Kidney Injury) to Genito Urinary System And Sex Hormones Clinical Trials, G7 Countries (%), 2017* 15
Acute Renal Failure (ARF) (Acute Kidney Injury) Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 17
Acute Renal Failure (ARF) (Acute Kidney Injury) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 18
Proportion of Acute Renal Failure (ARF) (Acute Kidney Injury) to Genito Urinary System And Sex Hormones Clinical Trials, E7 Countries (%), 2017* 20
Acute Renal Failure (ARF) (Acute Kidney Injury) Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 21
Acute Renal Failure (ARF) (Acute Kidney Injury) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 23
Acute Renal Failure (ARF) (Acute Kidney Injury) Therapeutics, Global, Clinical Trials by Phase (%), 2017* 26
Acute Renal Failure (ARF) (Acute Kidney Injury) Therapeutics, Global, Clinical Trials In Progress by Phase, 2017* 27
Acute Renal Failure (ARF) (Acute Kidney Injury) Therapeutics, Global, Clinical Trials by Trial Status, 2017* 28
Acute Renal Failure (ARF) (Acute Kidney Injury) Therapeutics Clinical Trials, Global, by End Point Status, 2017* 30
Acute Renal Failure (ARF) (Acute Kidney Injury) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 31
Acute Renal Failure (ARF) (Acute Kidney Injury) Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2017* 32
Acute Renal Failure (ARF) (Acute Kidney Injury) Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 33
Acute Renal Failure (ARF) (Acute Kidney Injury) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 35
Acute Renal Failure (ARF) (Acute Kidney Injury) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 37
GlobalData Methodology 217

$2,500.00

Research Assistance

We can help you find
data and analyses
relevant to your needs,
or prepare a custom report.

Please contact us at [email protected]
or +1 212 564 2838

 

Custom Research

Contact us to speak
with your industry analyst.

[email protected] 
+1 212 564 2838

 



Discount Codes

Request Discount Codes
for reports of interest to you.

[email protected]
+1 212 564 2838



Browse All Reports